Skip to content
10-Q

Quarterly Report

REVA Medical, Inc.

0001564590-18-027027

← back to feed
Filed
Nov 6, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 1, 2018 41.48M sh
Shares Diluted Q3 2018 · Sep 30, 2018 41.46M sh
Shares Diluted Q3 2018 · Sep 30, 2018 52.83M sh
Shares Diluted restated Q3 2018 · Sep 30, 2017 58.53M sh
Shares Diluted restated Q3 2018 · Sep 30, 2017 56.55M sh
Capex Q3 2018 · Sep 30, 2018 $820K
Capex Q3 2018 · Sep 30, 2017 $335K
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$12.15M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$14.84M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $7.09M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $18.54M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $22.61M
Cash And Equivalents Q3 2018 · Dec 31, 2016 $6.67M
Stockholders Equity Q3 2018 · Sep 30, 2018 −$73.27M
Stockholders Equity Q3 2018 · Dec 31, 2017 −$92.81M
Current Liabilities Q3 2018 · Sep 30, 2018 $2.94M
Current Liabilities Q3 2018 · Dec 31, 2017 $2.65M
Total Liabilities Q3 2018 · Sep 30, 2018 $83.9M
Total Liabilities Q3 2018 · Dec 31, 2017 $115.47M
Current Assets Q3 2018 · Sep 30, 2018 $8.73M
Current Assets Q3 2018 · Dec 31, 2017 $21.14M
Total Assets Q3 2018 · Sep 30, 2018 $10.63M
Total Assets Q3 2018 · Dec 31, 2017 $22.66M
Eps Diluted Q3 2018 · Sep 30, 2018 −$0.22
Eps Diluted Q3 2018 · Sep 30, 2018 −$0.31
Eps Diluted restated Q3 2018 · Sep 30, 2017 −$0.08
Eps Diluted restated Q3 2018 · Sep 30, 2017 −$0.33
Eps Basic Q3 2018 · Sep 30, 2018 −$0.22
Eps Basic Q3 2018 · Sep 30, 2018 $0.39
Eps Basic Q3 2018 · Sep 30, 2017 $0.15
Eps Basic Q3 2018 · Sep 30, 2017 $0.17
Sga Expense Q3 2018 · Sep 30, 2018 $2.82M
Sga Expense Q3 2018 · Sep 30, 2018 $9.25M
Sga Expense Q3 2018 · Sep 30, 2017 $1.69M
Sga Expense Q3 2018 · Sep 30, 2017 $5.77M
Rd Expense Q3 2018 · Sep 30, 2018 $1.73M
Rd Expense Q3 2018 · Sep 30, 2018 $6.67M
Rd Expense Q3 2018 · Sep 30, 2017 $3.09M
Rd Expense Q3 2018 · Sep 30, 2017 $10.14M
Net Income Q3 2018 · Sep 30, 2018 −$9.04M
Net Income Q3 2018 · Sep 30, 2018 $16.23M
Net Income Q3 2018 · Sep 30, 2017 $6.05M
Net Income Q3 2018 · Sep 30, 2017 $6.97M
Operating Income Q3 2018 · Sep 30, 2018 −$4.6M
Operating Income Q3 2018 · Sep 30, 2018 −$16M
Operating Income Q3 2018 · Sep 30, 2017 −$4.77M
Operating Income Q3 2018 · Sep 30, 2017 −$15.9M
Gross Profit Q3 2018 · Sep 30, 2018 −$48K
Gross Profit Q3 2018 · Sep 30, 2018 −$81K
Gross Profit Q3 2018 · Sep 30, 2017 $10K
Gross Profit Q3 2018 · Sep 30, 2017 $10K
Cost Of Revenue Q3 2018 · Sep 30, 2018 $141K
Cost Of Revenue Q3 2018 · Sep 30, 2018 $318K
Cost Of Revenue Q3 2018 · Sep 30, 2017 $7K
Cost Of Revenue Q3 2018 · Sep 30, 2017 $7K
Revenue Q3 2018 · Sep 30, 2018 $93K
Revenue Q3 2018 · Sep 30, 2018 $237K
Revenue Q3 2018 · Sep 30, 2017 $17K
Revenue Q3 2018 · Sep 30, 2017 $17K
Stock Repurchased Q3 2018 · Sep 30, 2017 $12.49M